Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NITROFURANTOIN | 100MG | CAPSULE | Actual shortage | 2024-06-13 | 2025-05-02 | 230320 |
| TEVA-NITROFURANTOIN | 50MG | CAPSULE | Actual shortage | 2024-08-08 | 2025-04-24 | 234873 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-11 | 1143 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-11-30 | 2024-01-11 | 211976 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-02-08 | 2024-06-20 | 218952 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-02-08 | 2025-03-20 | 218955 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-07-11 | 2024-10-11 | 232741 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2024-11-08 | 2025-03-27 | 242349 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-01-20 | 2022-03-24 | 153141 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Resolved | 2020-01-24 | 2020-07-10 | 104336 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-01-30 | 2020-12-03 | 104914 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-02-13 | 2020-04-09 | 106018 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-06-19 | 2023-07-14 | 195501 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-07-27 | 2023-08-04 | 200231 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2023-08-17 | 2023-12-14 | 202239 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2022-10-28 | 2022-12-15 | 173052 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Resolved | 2020-04-23 | 2020-11-26 | 113034 |
| TEVA-OLANZAPINE | 10MG | TABLET | Resolved | 2020-04-03 | 2020-05-29 | 110755 |
| TEVA-OLANZAPINE | 7.5MG | TABLET | Resolved | 2020-04-23 | 2020-05-14 | 113013 |
| TEVA-OLANZAPINE | 5MG | TABLET | Resolved | 2020-05-29 | 2020-07-23 | 116162 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Discontinued | 2025-03-20 | 2025-03-20 | 253186 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256091 |
| TEVA-FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256137 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |